Aid alignment for global health research: the role of HIROs by Viergever, Roderik F
COMMENTARY Open Access
Aid alignment for global health research:
the role of HIROs
Roderik F Viergever
Abstract
The lack of a mechanism that aligns financial flows for global health research towards public health priorities limits
the impact of health research on health and health equity. Collaborative groups of health research funders appear
to be particularly well situated to ameliorate this situation and to initiate discussion on aid alignment for global
health research. One such group is the Heads of International Research Organizations (HIROs), which brings
together a large number of major government and philanthropic funders of biomedical research. Surprisingly, there
is hardly any information publicly available on HIROs’ objectives, or on how it aims to achieve more harmonization
in the field of research for health. Greater transparency on HIROs’ objectives and on its current efforts towards
addressing the gap between global health research needs and investments would be desirable, given the
enormous potential benefits of more coordination by this group.
Introduction
“There is no global coordination of research and devel-
opment for major diseases, and the global health
research and innovation system is highly fragmented”
[1]. Such was one of the conclusions of the report of the
World Health Organization (WHO) Expert Working
Group on Research and Development Financing that
was finalized in the past year. This conclusion is not
novel; it has been consistently argued for decades that
the lack of a harmonized approach for prioritizing, fund-
ing, and planning research for health has prevented that
research from responding adequately to the world’s
health needs [2-4]. To this day, the allocation of health
research funding exhibits little tendency to be commen-
surate with burden of disease [5], and only a small per-
centage of funding is allocated towards research that
addresses the health problems of developing countries,
an issue often referred to as the 10/90 gap [2,6]. The
harmful consequences of this funding gap for everyday
clinical practice in developing countries are extensive.
For instance, in 2006 it was shown that 30 years of
pharmaceutical research had resulted in the develop-
ment of only 21 drugs targeting neglected diseases
(including malaria and tuberculosis) out of a total 1556
new chemical entities marketed [7]. Although the
emergence of public-private partnerships, increases in
total expenditure on global health research and in the
number of actors engaged in that research, and a shift
in epidemiology of disease in low- and middle-income
countries have all substantially changed the landscape of
health research for development in recent years, the
enduring mismatch between health research needs and
investments remains a cause for grave concern [6,8].
Discussion
The Global Ministerial Forum on Research for Health in
Bamako in 2008, in line with the Paris Declaration and the
A c c r aA g e n d af o rA c t i o n[ 9 ], recognized the need for
increased coordination in the field of research for health
and the important role of research funding institutions
therein [10]. It called on funders of research and innova-
tion “to better align, coordinate, and harmonize the global
health research architecture and its governance”.T h e r e
are several collaborative groups of funders of research for
health that appear to be well situated to achieve this. One
such group is the Heads of International Research Organi-
z a t i o n s( H I R O s ) .H I R O sw a se s t a b l i s h e dm o r et h a nt e n
years ago and brings together government and philanthro-
pic funding institutions for biomedical research, including
major funders such as the US National Institutes of Health
and the Bill and Melinda Gates Foundation [1]. The enor-
mous collective influence of these organizations is appar-
ent, but is also demonstrated by the impact external
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cations [11] and by research showing that a small group of
eleven organizations (many of which are a part of HIROs)
currently provide 75% of global funding for neglected dis-
ease research and development [5,12]. Besides HIROs,
there are other groups where funders of research for
health collaborate. Especially the ‘Enhancing Support for
Strengthening the Effectiveness of National Capacity
Efforts’ initiative (ESSENCE) - a collaborative framework
between funding agencies to scale up research capacity
and increase the effectiveness of research for health in
Africa - has recently made some encouraging first steps in
aligning donor funding towards national priorities for
health research [13]. Other examples are the Product
Development Partnership (PDP) Funders group (formerly
known as the PDP Donor Coordination Group), whose
purpose is to facilitate donors in supporting and monitor-
ing the performance of PDPs [14]; the International
Forum of Research Donors (IFORD), which brings
together funders of research related to international devel-
opment [15]; and the International Health Partnership+
(IHP+), which aims to improve the impact of health aid in
general [16].
In discussing the need for increased coordination
among funders of research for health, it is important to
consider what exactly needs to be coordinated. Recent
positive developments among funders include the identi-
fication of common approaches to monitoring and eva-
luation and sharing research data [17,18]. However,
funders have been found to fall short of agreeing on a
harmonized agenda for research funding [19]. This find-
ing is worrying; in order to maximize the impact of
research investments on health and health equity it is of
fundamental importance that funders agree on common
health research priorities, both in countries and on the
global level, and act on those priorities in a coordinated
manner [20-23].
Since HIROs brings together the heads of major fun-
ders of biomedical research, it appears to be particularly
well suited to give rise to the major changes in health
research governance that are called for by the Bamako
call to action. Unfortunately, HIROs has made little
information available on its goals or on how it aims to
achieve increased harmonization, alignment and coordi-
nation. An internet search reveals only websites noting
that a meeting has taken place, and a search on PubMed
for “Heads of International Research Organisations” OR
“Heads of International Research Organizations” OR
“Heads of International biomedical Research Organisa-
tions” OR “Heads of International biomedical Research
Organizations” OR HIRO[Title/Abstract] OR HIROs
[Title/Abstract] returns no relevant results. HIROs is not
the only group where funders collaborate that is sparing
with information. Recently, IHP+ was criticized for its
lack of transparency [24]. Individual funders have also
been criticized for not being transparent enough in their
operations [25].
Conclusion
An initiative like the HIROs group is most welcome in
the crowded field of global health research funders. It is
surely one of the few groups that could initiate discussion
on aid alignment for global health research. Given the
enormous potential benefits of more coordination by this
group, the contents of its discussions are of great interest
to the global health research community. More transpar-
ency on HIROs’ intentions for achieving increased coor-
dination and on its current efforts towards addressing the
gap between global health research needs and invest-
ments would therefore be desirable.
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